NCT00934102

Brief Summary

The purpose of this study is to assess the ophthalmic compatibility of three different silicone hydrogel lenses worn on an overnight basis for six nights.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 8, 2009

Completed
24 days until next milestone

Study Start

First participant enrolled

August 1, 2009

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

December 1, 2010

Completed
Last Updated

July 10, 2012

Status Verified

November 1, 2010

Enrollment Period

1 month

First QC Date

July 6, 2009

Results QC Date

November 1, 2010

Last Update Submit

June 26, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Front Surface Lens Deposits

    Protein and lipid deposits on the contact lens surface as assessed by the investigator using a biomicroscope, which magnifies the appearance of the contact lens on the wearer's eye. Deposits were graded on a scale of 0 to 4 with 0 being none and 4 being severe.

    Period 2, Day 6

Study Arms (3)

Lotrafilcon A

ACTIVE COMPARATOR

Lotrafilcon A, silicone hydrogel, spherical contact lens randomly assigned to one eye, worn on an extended wear basis.

Device: Lotrafilcon A contact lens

Narafilcon A

ACTIVE COMPARATOR

Narafilcon A, silicone hydrogel, spherical contact lens randomly assigned to one eye, worn on an extended wear basis.

Device: Narafilcon A contact lens

Galyfilcon A

ACTIVE COMPARATOR

Galyfilcon A, silicone hydrogel, spherical contact lens randomly assigned to one eye, worn on an extended wear basis.

Device: Galyfilcon A contact lens

Interventions

Investigational, silicone hydrogel, spherical soft contact lens

Narafilcon A

Commercially marketed, silicone hydrogel, spherical soft contact lens

Lotrafilcon A

Commercially marketed, silicone hydrogel, spherical soft contact lens

Galyfilcon A

Eligibility Criteria

Age17 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Is at least 17 years of age and has full legal capacity to volunteer
  • Is correctable to a visual acuity of 20/30 or better (in each eye) with their habitual vision correction
  • Has had an ocular examination in the last two years
  • Is a current soft (hydrogel or silicone hydrogel) contact lens wearer
  • Has clear corneas and no active ocular disease
  • Can be successfully fit with the lenses to be used in the study

You may not qualify if:

  • Is pregnant or lactating
  • Has undergone corneal refractive surgery
  • Currently wears lenses on an extended wear basis or was on extended wear within six months prior to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Contact Lens Research: University of Waterloo

Waterloo, Ontario, N2L 3G1, Canada

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Craig Woods, PhD, FAAO / Research Manager
Organization
University of Waterloo

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2009

First Posted

July 8, 2009

Study Start

August 1, 2009

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

July 10, 2012

Results First Posted

December 1, 2010

Record last verified: 2010-11

Locations